Literature DB >> 16701840

Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model.

Elizabeth A Lipke1, Jennifer L West.   

Abstract

Using novel nitric oxide (NO)-generating polymeric hydrogels that can be rapidly photopolymerized in situ, we can deliver NO locally at the site of vascular injury. Depending on material design, these poly(ethylene glycol) (PEG)-based hydrogels can generate NO for up to 50 d. This study demonstrates the ability of nitric oxide-generating hydrogels (PEG-Cys-NO) to influence key components of the restenosis cascade both in vitro and in vivo. PEG-Cys-NO hydrogels inhibited smooth muscle cell proliferation, increased endothelial cell proliferation, and inhibited platelet adhesion in vitro. Moreover, in vivo, PEG-Cys-NO hydrogels inhibited intimal thickening in a rat carotid balloon injury model. The perivascular application of NO-generating polymers post-injury reduced neointima formation at 14 d by approximately 80% compared to controls (intimal area/medial area (I/M): PEG-Cys-NO=0.20+/-0.17, control=0.84+/-0.19, p<0.00002; intimal thickness: PEG-Cys-NO=12+/-10 microm, control=60+/-18 microm, p<0.00002). Treatment with the PEG-Cys-NO hydrogels caused a significant decrease in the per cent of proliferating cell nuclear antigen positive medial cells (29+/-5%) at 4 d as compared to treatment with the control hydrogels (51+/-1%, p<0.02). Additionally, vessel re-endothelialization at 14 d was slightly enhanced in the presence of the NO-generating hydrogels. These data indicate that localized delivery of NO from these hydrogels can significantly inhibit neointima formation in a rat carotid balloon injury model and suggest that these materials may be useful in preventing restenosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16701840     DOI: 10.1016/j.actbio.2005.07.010

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  19 in total

1.  Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft.

Authors:  Shawn C Owen; Huan Li; William G Sanders; Alfred K Cheung; Christi M Terry
Journal:  J Control Release       Date:  2010-05-08       Impact factor: 9.776

2.  A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants.

Authors:  Adinarayana Andukuri; Meenakshi Kushwaha; Ajay Tambralli; Joel M Anderson; Derrick R Dean; Joel L Berry; Young Doug Sohn; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

Review 3.  S-Nitrosothiol biology and therapeutic potential in metabolic disease.

Authors:  Christopher G Kevil; Rakesh P Patel
Journal:  Curr Opin Investig Drugs       Date:  2010-10

4.  Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.

Authors:  Michele C Jen; María C Serrano; Robert van Lith; Guillermo A Ameer
Journal:  Adv Funct Mater       Date:  2012-01-25       Impact factor: 18.808

5.  Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia.

Authors:  M Concepcion Serrano; Ashley K Vavra; Michele Jen; Melissa E Hogg; Jozef Murar; Janet Martinez; Larry K Keefer; Guillermo A Ameer; Melina R Kibbe
Journal:  Macromol Biosci       Date:  2011-02-21       Impact factor: 4.979

6.  Electrospun biodegradable elastic polyurethane scaffolds with dipyridamole release for small diameter vascular grafts.

Authors:  Primana Punnakitikashem; Danh Truong; Jyothi U Menon; Kytai T Nguyen; Yi Hong
Journal:  Acta Biomater       Date:  2014-08-08       Impact factor: 8.947

7.  Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures.

Authors:  Phillip Simmers; Arsela Gishto; Narendra Vyavahare; Chandrasekhar R Kothapalli
Journal:  Tissue Eng Part A       Date:  2015-03-09       Impact factor: 3.845

Review 8.  Local drug delivery to prevent restenosis.

Authors:  Stephen M Seedial; Soumojit Ghosh; R Scott Saunders; Pasithorn A Suwanabol; Xudong Shi; Bo Liu; K Craig Kent
Journal:  J Vasc Surg       Date:  2013-05       Impact factor: 4.268

9.  Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.

Authors:  Muneera R Kapadia; Lesley W Chow; Nick D Tsihlis; Sadaf S Ahanchi; Jason W Eng; Jozef Murar; Janet Martinez; Daniel A Popowich; Qun Jiang; Joseph A Hrabie; Joseph E Saavedra; Larry K Keefer; James F Hulvat; Samuel I Stupp; Melina R Kibbe
Journal:  J Vasc Surg       Date:  2008-01       Impact factor: 4.268

10.  Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel.

Authors:  Rafael Vercelino; Thiago Mattar Cunha; Elisa Silva Ferreira; Fernando Q Cunha; Sérgio H Ferreira; Marcelo G de Oliveira
Journal:  J Mater Sci Mater Med       Date:  2013-06-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.